Northwestern Mutual Wealth Management’s Abivax ABVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$533 Sell
4
-2
-33% -$226 ﹤0.01% 3878
2026
Q1
$668 Buy
6
+3
+100% +$355 ﹤0.01% 3816
2025
Q4
$405 Buy
+3
New +$327 ﹤0.01% 3744

Other funds holding ABVX

Northwestern Mutual Wealth Management's ABVX Position: Q2 2026 in Review

Northwestern Mutual Wealth Management reduced its Abivax (ABVX) stake by 33% in Q2 2026, selling an estimated $226 and leaving 4 shares worth $533. The position accounts for ﹤0.01% of the portfolio, ranked #3878.

Northwestern Mutual Wealth Management first reported a position in ABVX in Q4 2025 and has held it in 3 quarters since. The position peaked at $668 in Q1 2026. 303 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Northwestern Mutual Wealth Management held 4 shares of Abivax worth $533 as of Q2 2026.
  • Northwestern Mutual Wealth Management sold 2 Abivax shares in Q2 2026, an estimated $226.
  • Abivax made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3878 holding.
  • Northwestern Mutual Wealth Management first reported a position in Abivax in Q4 2025 and has held it in 3 quarters since.
  • Northwestern Mutual Wealth Management's Abivax position peaked at $668 in Q1 2026.
  • 303 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.